SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 64 filers reported holding SIO GENE THERAPIES INC in Q4 2020. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sassicaia Capital Advisers LLC | 310,500 | $863,000 | 1.79% |
| Consonance Capital Management LP | 3,186,335 | $8,858,000 | 0.83% |
| Opaleye Management Inc. | 2,000,000 | $5,560,000 | 0.73% |
| Sio Capital Management, LLC | 886,665 | $2,465,000 | 0.50% |
| Rubric Capital Management LP | 2,335,200 | $6,492,000 | 0.48% |
| Affinity Asset Advisors, LLC | 250,000 | $695,000 | 0.37% |
| GSA CAPITAL PARTNERS LLP | 354,265 | $985,000 | 0.16% |
| Hudson Bay Capital Management LP | 3,200,000 | $8,896,000 | 0.05% |
| Insight Advisors, LLC/ PA | 24,000 | $67,000 | 0.02% |
| Maven Securities LTD | 86,788 | $246,000 | 0.02% |